Go to content
UR Home

Anti-Thymocyte Globulin Treatment Augments 1,25-Dihydroxyvitamin D3 Serum Levels in Patients Undergoing Hematopoietic Stem Cell Transplantation

URN to cite this document:
DOI to cite this document:
Matos, Carina ; Peter, Katrin ; Weich, Laura ; Peuker, Alice ; Schoenhammer, Gabriele ; Roider, Tobias ; Ghimire, Sakhila ; Babl, Nathalie ; Decking, Sonja ; Güllstorf, Martina ; Kröger, Nicolaus ; Hammon, Kathrin ; Herr, Wolfgang ; Stark, Klaus ; Heid, Iris M. ; Renner, Kathrin ; Holler, Ernst ; Kreutz, Marina
[img]License: Creative Commons Attribution 4.0
PDF - Published Version
Date of publication of this fulltext: 09 May 2023 05:39


Application of anti-thymocyte globulin (ATG) is a widely used strategy for the prevention of graft-versus-host disease (GvHD). As vitamin D3 serum levels are also discussed to affect hematopoietic stem cell transplantation (HSCT) outcome and GvHD development, we analysed a possible interplay between ATG treatment and serum levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in 4 HSCT ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons